Clinico-biological Data Collection Study of Metastatic Lung Cancer
ConditionLung Cancer
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorInstitut Cancerologie de l'Ouest
About this trial
RATIONALE : Currently, the mechanisms associated with the response or resistance to treatment are poorly understood and are multifactorial. These mechanisms involve clinical and biological factors associated with the host and the tumor and possibly the patient's psycho-social environment.
PURPOSE : This trial will assess the use of a prospective database dedicated to patients with breast cancers that contains clinical data as well as epidemiological, psychological, emotional, social, imaging, biological and biopathological data. These data will allow a creation of new modelling algorithms in order to predict response and resistance to treatment.
Eligibility criteria
Qualifiers
Written informed consent obtained from the patient prior to performing any protocol-related procedures, including screening biopsy, blood sample and questionnaires
18 years old at time of written consent
Patient with histologically confirmed lung cancer
Lung cancer metastatic disease or locally advanced not eligible for local curative treatment intent
Disqualifiers
Other malignancy treated within the last 3 years (except non-melanoma skin cancer or in situ carcinoma of the cervix)
Other neuroendocrine tumour than small cell or large cell carcinoma.
Pregnant or nursing patient
Individual deprived of liberty or placed under the authority of a tutor
Trial design
Treatments tested in this trial
- Metastasis biopsy
Treatment groups
200 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov